ONCAlert | 2018 Gastrointestinal Cancers Symposium

The Benefits of Venetoclax in CLL

Jeffrey Jones, MD, MPH
Published Online: 7:46 PM, Sun December 4, 2016

Jeffrey Jones, MD, MPH, associate professor of Internal Medicine, Division of Hematology, Department of Internal Medicine, Ohio State University Wexner Medical Center, discusses the benefits of venetoclax in chronic lymphocytic luekemia (CLL).

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.